SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-020225
Filing Date
2022-05-31
Accepted
2022-05-31 18:34:11
Documents
2
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1534
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 2309
  Complete submission text file 0000899243-22-020225.txt   5274
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CODIAK BIOSCIENCES, INC. 500 TECHNOLOGY SQUARE, 9TH FLOOR CAMBRIDGE MA 02139
Business Address
Konstantinov Konstantin (Reporting) CIK: 0001774649 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-14656 | Film No.: 22985151